Eton Pharmaceuticals

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$21,281
$22,459
$18,928
$17,282
Gross Profit
13,100
7,855
11,924
9,861
EBITDA
3,487
265
-470
543
EBIT
2,471
-743
-1,475
-470
Net Income
1,483
-1,927
-2,585
-1,572
Net Change In Cash
21,281
22,459
18,928
17,282
Free Cash Flow
-22,124
11,742
7,959
2,090
Cash
25,942
37,121
25,379
17,420
Basic Shares
26,908
26,893
26,893
26,886

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$79,950
$39,011
$31,642
$21,251
Gross Profit
42,740
23,411
21,061
14,318
EBITDA
4,115
-1,451
-291
-6,486
EBIT
72
-2,597
-1,192
-8,260
Net Income
-4,601
-3,823
-936
-9,021
Net Change In Cash
79,950
39,011
31,642
21,251
Cost of Revenue
1,899
Free Cash Flow
10,191
943
6,040
2,033
Cash
25,942
14,936
21,388
16,305
Basic Shares
26,908
25,895
25,645
25,146

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
$0.19
2025-09-30
$0.04
2025-06-30
-$0.10